Despite Fierce Debate

F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works

отличная реклама

и далее поясняется: Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.